Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 1 003 JPY 6.93%
Market Cap: 28.2B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharma Foods International Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Retained Earnings
ÂĄ8.3B
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Retained Earnings
ÂĄ10.1B
CAGR 3-Years
125%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PeptiDream Inc
TSE:4587
Retained Earnings
ÂĄ52B
CAGR 3-Years
44%
CAGR 5-Years
39%
CAGR 10-Years
63%
Takara Bio Inc
TSE:4974
Retained Earnings
ÂĄ51.9B
CAGR 3-Years
14%
CAGR 5-Years
25%
CAGR 10-Years
21%
S
StemRIM Inc
TSE:4599
Retained Earnings
-ÂĄ538.9m
CAGR 3-Years
N/A
CAGR 5-Years
12%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Retained Earnings
-ÂĄ2.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
28.1B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 599.9 JPY
Undervaluation 61%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Retained Earnings?
Retained Earnings
8.3B JPY

Based on the financial report for Oct 31, 2024, Pharma Foods International Co Ltd's Retained Earnings amounts to 8.3B JPY.

What is Pharma Foods International Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 3Y
17%

Over the last year, the Retained Earnings growth was 45%. The average annual Retained Earnings growth rates for Pharma Foods International Co Ltd have been 17% over the past three years .

Back to Top